BackParatek Pharmaceuticals Overview

Paratek Pharmaceuticals Net Income

Profitability analysis for PRTK.

Quarterly Net Income

-$14.55M
↑ 17.4% YoY

As of Jun 2023

Annual Net Income (TTM)

-$62.73M
↑ 27.04% YoY

Trailing 12 months ending Jun 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin